July 6, 2021
1 min read

Oxford scientists launch HIV vaccine trial

At present, prevention of HIV largely focuses on behavioural and biomedical interventions such as voluntary medical male circumcision…reports Asian Lite News.

Scientists at the University of Oxford have started vaccinations of a novel HIV vaccine candidate as part of a Phase I clinical trial in the UK.

The goal of the trial is to evaluate the safety, tolerability and immunogenicity of the HIVconsvX vaccine — a mosaic vaccine targeting a broad range of HIV-1 variants, making it potentially applicable for HIV strains in any geographical region.

Thirteen healthy, HIV-negative adults, aged 18-65 and who are considered not to be at high risk of infection, will initially receive one dose of the vaccine followed by a further booster dose at four weeks.

“An effective HIV vaccine has been elusive for 40 years. This trial is the first in a series of evaluations of this novel vaccine strategy in both HIV-negative individuals for prevention and in people living with HIV for cure,” said lead researcher Tomas Hanke, Professor of Vaccine Immunology at the Jenner Institute at Oxford, in a statement.

While most HIV vaccine candidates work by inducing antibodies generated by B-cells, HIVconsvX induces the immune system’s potent, pathogen obliterating T cells, targeting them to highly conserved and therefore vulnerable regions of HIV — an “Achilles heel” common to most HIV variants.

“Achieving protection against HIV is extremely challenging and it is important that we harness the protective potential of both the antibody and T cell arms of the immune system,” said Paola Cicconi, Senior Clinical Research Fellow at the Jenner Institute.

At present, prevention of HIV largely focuses on behavioural and biomedical interventions such as voluntary medical male circumcision, condom use, and anti-retroviral drugs used prior to exposure.

The researchers aim to report results of the trial by April 2022. Similar trials are also planned in Europe, Africa and the US.

ALSO READ-UAE approves Moderna vaccine for emergency use

READ MORE-US to send 4 million doses of vaccine to India

Previous Story

EU slams Israel’s measures in E.Jerusalem

Next Story

Rs 18 cr raised through crowd funding for Kerala kid

Latest from -Top News

‘A Day to Rejoice’

In its statement, British Friends of Israel saluted the courage and resilience of the hostages and expressed deep sorrow for those who did not survive captivity After 737 days of anguish, the

UK to Lead Gaza Rebuild

PM announces an additional £20 million aid package aimed at providing essential water, sanitation and hygiene services to tens of thousands of people Prime Minister Keir Starmer attended the signing ceremony of

UN Faces Crisis, Says Rajnath

Rajnath Singh said India recognises that the success of peacekeeping depends not only on numbers but on preparedness….reports Asian Lite News Defence Minister Rajnath Singh on Tuesday highlighted the urgent need for

UK to host summit on Gaza recovery plan

The three-day conference, beginning Monday afternoon, will take place at Wilton Park, the Foreign Office’s policy forum based in West Sussex The UK will host an international summit on the recovery and

India, Australia Begin AUSTRAHIND

The AUSTRAHIND exercise, which followed Defence Minister Rajnath Singh’s recent visit to Australia, reaffirmed the deepening defence cooperation between the two nations…reports Asian Lite News Strengthening the expanding defence partnership between India
Go toTop